Bair Hugger Lawsuit Update 2026: MDL 2666 Settlement Fund News

Here is the Bair Hugger lawsuit update for 2026. If you suffered a serious infection after orthopedic surgery such as a hip or knee replacement, and a Bair Hugger forced-air warming blanket was used during the operation, you may have a Bair Hugger lawsuit. Over 8,400 claims are pending in MDL 2666, and a 2026 request to set up a Qualified Settlement Fund could be the biggest development the litigation has seen. Below is what has been confirmed so far and what you can do now to protect your rights.

What the Bair Hugger Lawsuit Claims

Bair Hugger claims are brought by patients who developed deep periprosthetic joint infections — often MRSA or other serious bacterial infections — after hip or knee replacements during which a Bair Hugger forced-air warmer was used. They allege that 3M and its subsidiary Arizant Healthcare designed and sold a device that disturbs the carefully controlled laminar airflow in orthopedic operating rooms, driving contaminated particles into open incisions.

The Bair Hugger is the leading patient-warming system in U.S. hospitals, commonly estimated to be used in 80–90% of operating rooms. It keeps a patient’s core temperature stable during surgery, which is medically important, and plaintiffs do not challenge that purpose. Their argument is that 3M’s chosen design carries a serious, undisclosed infection risk for joint replacement patients, for whom an infection can be devastating and permanent.

The injuries alleged include deep joint infections needing several revision surgeries, sepsis, MRSA, lasting joint problems, amputation, and, in the worst cases, death. For a broader look at this litigation, read our full Bair Hugger lawsuit guide, or browse Legal Lawsuit’s mass tort resources for related cases.

Bair Hugger Lawsuit Update: June 2026

As of June 2026, roughly 8,422 active Bair Hugger claims were pending in MDL No. 15-2666 (In re: Bair Hugger Forced Air Warming Devices Products Liability Litigation) before Judge Joan N. Ericksen and Magistrate Judge David T. Schultz in the U.S. District Court for the District of Minnesota, placing it among the country’s largest active medical device MDLs. The headline development is a sealed filing seeking permission to create a Qualified Settlement Fund (QSF), which would provide the formal structure for resolving thousands of claims against 3M.

The QSF request is the first tangible move toward a global resolution after roughly a decade of litigation. Its terms — amounts, eligibility tiers, and deadlines — are sealed and not public, but the filing suggests the parties are negotiating seriously under Special Master James M. Rosenbaum (Ret.). As of this update, no global resolution has been officially announced.

Getting here took years. The MDL was formed in 2015, and the first bellwether trial in 2018 ended with a defense verdict for 3M. In 2019, the court excluded the plaintiffs’ general causation experts and dismissed the whole MDL, which seemed to end the case. Plaintiffs appealed, and in August 2021 the Eighth Circuit reversed, finding their scientific evidence sufficient to move forward. The Supreme Court declined 3M’s appeal in June 2022, and the MDL officially reopened in December 2022.

In February 2025, the Eastern District of Pennsylvania ruled in Boncher v. 3M that the plaintiff’s infection-causation expert could testify under Rule 702 and denied summary judgment, keeping alive the central theory that the Bair Hugger can cause periprosthetic joint infections. Together with a case count now above 8,400, that ruling has likely helped spur settlement talks. The Shirley Hilke v. 3M bellwether trial wrapped up in 2026, and its appeal is being briefed in the Eighth Circuit.

The Settlement Fund and What We Know

The request for a Qualified Settlement Fund is the most important event in the Bair Hugger MDL in years. A QSF, also called a “468B fund,” is a court-approved legal vehicle that lets a defendant deposit money to resolve claims before every individual payment is worked out. Creating one indicates that a framework for a global resolution is under construction.

Confirmed: The parties have asked the court for permission to create a Qualified Settlement Fund, and that filing exists.

Not yet confirmed: How much will go into the fund, who will be eligible, how payments may be tiered by injury severity, and any filing deadlines — all still sealed. Neither 3M nor Arizant has announced a settlement amount, so treat any dollar figure you see elsewhere as a guess, not a confirmed offer.

What will likely drive value: Because the fund’s terms are sealed, there are no reliable settlement figures yet, and published dollar predictions are speculation. What can be said is that claims involving MRSA, sepsis, several revision surgeries, permanent disability, or wrongful death are generally expected to be valued well above claims involving milder, quickly resolved infections. To explore how these factors apply to you, see if you may qualify for a similar recovery using our settlement calculator.

Who Can File a Bair Hugger Claim?

Since official eligibility rules for the Qualified Settlement Fund have not been released, the exact requirements are still unknown. Attorneys currently filing in MDL 2666, however, generally look for the following:

• Hip or knee replacement surgery — A Bair Hugger was used during your operation, which is usually noted in surgical and anesthesia records.
• A deep infection after surgery — You developed a deep periprosthetic joint infection, MRSA, sepsis, or a similarly serious infection. Surface wound infections may not qualify; the infection generally must reach the joint or bone.
• Records connecting the device and the infection — Hospital records, operative notes, and infection diagnoses are needed, and the sooner the infection appeared after surgery, the clearer the possible connection.
• Filing deadlines — Deadlines differ by state, commonly 2–4 years from the injury or its discovery, and some may already have expired for older surgeries. Prompt action matters.
• Seriousness of the injury — Revision surgery, long hospital stays, permanent joint damage, amputation, or death make for the strongest claims. Milder infections that cleared quickly may still qualify, though they are valued differently.
• Wrongful death claims — Relatives of patients who died from a Bair Hugger-related infection may be able to file on behalf of the estate.

Keep in mind that 3M has argued, and the Eighth Circuit recognized, that proving a particular patient’s infection came from the Bair Hugger rather than another source in the operating room is a real evidentiary hurdle. An experienced mass tort attorney can tell you whether your facts support a strong causation case. You can also look into other active mass tort lawsuits that may apply to you.

What Determines the Value of a Bair Hugger Case?

Each Bair Hugger claim’s value turns on injury-specific factors. With the fund’s terms still sealed, attorneys use these factors to assess, not promise, what a case may be worth. For a personalized look at your situation, estimate what your case could be worth now with our settlement calculator.

How severe the infection was matters most. A deep joint infection that progressed to sepsis or MRSA bloodstream infection, requiring ICU care, IV antibiotics, and removal of the implant, will likely be valued far higher than a contained infection cleared with one round of antibiotics. The number of revision surgeries also directly affects both economic damages (medical bills) and non-economic damages (pain, suffering, and lost quality of life).

Lasting disability or loss of function is another major factor. People left with an unstable joint, an implant that could not be replaced, limited mobility, or a leg amputation generally have the strongest damages claims. Lost income and reduced earning ability, particularly for working-age plaintiffs whose careers were disrupted or ended, also carry significant weight in comparable mass torts.

How long the illness lasted and how much treatment it required also matter. Years of follow-up surgery, continuing antibiotics, and ongoing joint problems generally produce larger documented economic losses and support a stronger case for compensation. That wide range of injury experiences is why there is no single standard payout.

Steps to File a Bair Hugger Lawsuit

Filing a Bair Hugger lawsuit, or registering a claim ahead of a Qualified Settlement Fund, is a fairly simple process, but timing and records are crucial. Most claimants can expect these steps:

1. Free case review — An experienced mass tort attorney examines your surgical and hospital records and infection diagnosis to see whether you meet the basic MDL 2666 criteria, at no cost to you.
2. Collecting records — The attorney requests your surgical and follow-up records, including operating-room logs showing Bair Hugger use, anesthesia records, culture results identifying the infection, and records of revision surgeries.
3. Filing or registering the claim — Depending on where the Qualified Settlement Fund stands when your claim is ready, your attorney will either file a complaint in MDL 2666 in the District of Minnesota or register your claim with the settlement administrator. Registering early generally puts claimants in a better position in any eventual payment framework.
4. Discovery and expert analysis — Your legal team works with medical and engineering experts to show that (a) a Bair Hugger was used in your surgery, (b) you developed a qualifying infection, and (c) the infection is causally connected to the device — the most disputed issue in the litigation.
5. Settlement or trial — MDL cases may be resolved through the Qualified Settlement Fund if it is approved, or move on to bellwether trials. Cases filed in state court may also be settled through direct negotiations with 3M’s lawyers.

Deadlines matter a great deal. Many states allow 2–4 years from the injury or its discovery to file, and some people with older infections may be close to, or past, their cutoff. With the Qualified Settlement Fund under development, talking to an attorney right away is the most important thing you can do.

For scientific background on the Bair Hugger and infection, search PubMed/NIH, where you will find orthopedic and infectious disease studies on forced-air warming and periprosthetic infection risk. The Eighth Circuit’s August 2021 reversal in MDL 2666, available from the Eighth Circuit Court of Appeals, sets the legal framework the litigation now follows.

Common Questions

Related Articles